Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| ALG-H52E1 | Human | Biotinylated Human ALPG / ALPPL2 Protein, His,Avitag™ (MALS verified) |  |
|
|
| ALG-M52H9 | Mouse | Mouse ALPG / ALPPL2 Protein, His Tag (active enzyme, MALS verified) |  |
|
|
| ALG-H52H9 | Human | Human ALPG / ALPPL2 Protein, His Tag (active enzyme, MALS verified) |  |
|
|
Immobilized Human ALPG, His Tag (Cat. No. ALG-H52H9) at 1 μg/mL (100 μL/well) can bind Anti - ALPG / ALPPL2 with a linear range of 0.002-0.125 μg/mL (QC tested).
The purity of Biotinylated Human ALPG Protein, His,Avitag (Cat. No. ALG-H52E1) is more than 90% and the molecular weight of this protein is around 115-135 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Amifostine | NSC-296961; YM-08310; S-8744; SAPEP; WR-2721; WR-2721C | Approved | Medimmune Llc | 天地达, 安福定, Ethyol | United States | Head and Neck Neoplasms; Ovarian Neoplasms | Clinigen Inc | 1995-12-08 | Cytoprotective adjuvant; Myelodysplastic-Myeloproliferative Diseases; Mucositis; Salivary Gland Diseases; Lung Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma; Bone Marrow Diseases; Acute Radiation Syndrome; Prostatic Neoplasms; Breast Neoplasms; Sarcoma; Radiation Injuries; Ovarian Neoplasms; Neurotoxicity Syndromes; Gestational Trophoblastic Disease; Nasopharyngeal Neoplasms; Hodgkin Disease; Fanconi Anemia; Myelodysplastic Syndromes; Carcinoma; Neutropenia; Trigeminal Neuralgia; Peripheral Nervous System Diseases; Head and Neck Neoplasms; Solid tumours | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| ALXN-1850 | ALXN-1850 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Hypophosphatasia | Details |
This web search service is supported by Google Inc.
A-Z
